
ACCURAY INC
ARAYNASDAQTrading Snapshot
- Day Range
- $0.28 β $0.29
- 52-Week Range
- $0.22 β $2.10
- Volume
- $3.12B
- Avg Volume
- $2.65B
- Shares Outstanding
- 119.0M
- Next Earnings
- Oct 4, 2026
Fundamentals Snapshot
- Annual Revenue
- $459M
- Last Q Revenue
- $105M
- P/E Ratio
- -0.8
- P/S Ratio
- 0.1x
- EPS (TTM)
- $-0.37
- Dividend Yield
- 0.00%
Why Investors Own ARAY
- βHigh-growth profile β revenue up +11.1% YoY with expanding US Equity exposure.
- βHealthy economics β 77% gross margin and 27% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About ACCURAY INC
Accuray Incorporated specializes in the design, development, production, and sale of advanced radiosurgery and radiation therapy equipment aimed at treating tumors. Their market footprint spans across North and South America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the broader Asia Pacific region. Among their core offerings is the CyberKnife System, a sophisticated robotic platform for stereotactic radiosurgery and stereotactic body radiation therapy. This system is employed to target both primary and metastatic tumors located outside the brain, specifically addressing areas such as the spine, breast, kidney, liver, lung, pancreas, and prostate. They also provide the TomoTherapy System, which encompasses the Radixact System, designed to deliver highly precise radiation treatments (up to 50 patients daily) through integrated planning, delivery, and data management capabilities. Complementing these are the iDMS data management system and the Accuray precision treatment planning system, both offering comprehensive solutions for treatment planning and data handling. In addition to their technology, Accuray offers crucial post-sale services, including customer support, system installation, training, and various other professional services. The company primarily engages directly with its clientele, which includes hospitals and specialized treatment centers, through its dedicated sales force. In the United States, they also leverage sales agents and group purchasing organizations, while internationally, their reach extends through distributors and sales agents. Established in 1990, Accuray Incorporated maintains its corporate headquarters in Madison, Wisconsin.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
ACCURAY INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift ARAY price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
ACCURAY INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.